ICD-10 category · Chapter XX · Y40-Y59

Y55 Adverse effects in therapeutic use, agents primarily acting on smooth and skeletal muscles and the respiratory system

9 codes under Y55 in the South African Master Industry Table 2021, 8 valid for clinical use.

Valid: the code is at its most specific level and may go on an account. Heading only: code to a more specific entry beneath it. PMB and CDL: a Prescribed Minimum Benefit or Chronic Disease List condition per the Council for Medical Schemes. † dagger and * asterisk codes are used as a pair. How to read the table
Code	Description	Use	Benefits
Y55	Adverse effects in therapeutic use, agents primarily acting on smooth and skeletal muscles and the respiratory system	Heading only	—
Y55.0	Adverse effects in therapeutic use, oxytocic drugs	Valid · not as primary	—
Y55.1	Adverse effects in therapeutic use, skeletal muscle relaxants [neuromuscular blocking agents]	Valid · not as primary	—
Y55.2	Adverse effects in therapeutic use, other and unspecified agents primarily acting on muscles	Valid · not as primary	—
Y55.3	Adverse effects in therapeutic use, antitussives	Valid · not as primary	—
Y55.4	Adverse effects in therapeutic use, expectorants	Valid · not as primary	—
Y55.5	Adverse effects in therapeutic use, anti-common-cold drugs	Valid · not as primary	—
Y55.6	Adverse effects in therapeutic use, antiasthmatics, not elsewhere classified	Valid · not as primary	—
Y55.7	Adverse effects in therapeutic use, other and unspecified agents primarily acting on the respiratory system	Valid · not as primary	—

Source and terms

Reproduced from the national table, unaltered.

The Department publishes the table for the industry to load. The ICD-10 Master Industry Table page

Codes and descriptions: ICD-10 Master Industry Table (MIT) 2021, published 16 March 2021 by the National Department of Health, Republic of South Africa. ® National Department of Health: all rights reserved. Reproduced for reference without alteration.

ICD-10 is the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, © World Health Organization. The WHO ICD-10 descriptions appear as published in the MIT.

Prescribed Minimum Benefit (PMB) and Chronic Disease List (CDL) markers: Council for Medical Schemes, PMB Coded List, as read by GreenNotes. Benefit decisions rest with each medical scheme.

Source file: ICD-10_MIT_2021_Excel_16-March_2021.xlsx. Found an error in a code or description? Write to help@greennotes.co.za.

This lookup is a reference to the published code table, not coding advice. Code assignment is the treating practitioner’s responsibility, following the South African ICD-10 Coding Standards and Guidelines and the WHO ICD-10 volumes. GreenNotes does not warrant that the table is complete or current.

This is the South African table. Most ICD-10 results online are the United States’ ICD-10-CM, a different code set that South African medical schemes do not accept. Regulation 5 of the General Regulations under the Medical Schemes Act requires the diagnostic code on every account, and the Master Industry Table is the list it is coded from.

In GreenNotes

Code the consultation once. The invoice and the claim pick it up.

GreenNotes looks codes up from this same table while you write the consultation. The codes you record there, including any the clinical AI included for your review, carry into the invoice and the medical-aid claim.

Start a 14-day Clinical trial See notes become claims